IVAX Diagnostics, Inc. (IVD), a fully integrated in vitro diagnostics company, reported a narrower first-quarter net loss of $78,454 or breakeven per share, compared to the net loss of $1.0 million or $0.04 per share in the year-ago quarter.
Net revenues for the quarter rose 3.4 percent to $4.3 million from $4.1 million a year ago, mainly due to an increase in reagent and instrument sales in the United States and contract R&D revenues in Italy.
Operating expenses decreased to $2.2 million from $3.1 million in the year-ago first quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.